What question did this study set out to answer?

This research aims to detail the clinical presentation and management strategies for immune checkpoint inhibitor-associated myocarditis.

April 1, 2026Cardiology in Review

Immune Checkpoint Inhibitor–Associated Myocarditis: Current Understanding of Clinical Presentation and Management

View Full Paper

Ask AI

Bookmark

Key result

Prompt high-dose corticosteroids linked to improved outcomes in life-threatening ICI-associated myocarditis.

Why the study?

As immune checkpoint inhibitors are increasingly used across earlier disease stages, prolonged durations, and combination regimens, the clinical burden of rare but life-threatening myocarditis is expected to rise.

Design

Review

Authors

JTJatin ThukralNew York Medical College PMPyush MoudgilGian Sagar Medical College and Hospital JRJairul RohewalGian Sagar Medical College and Hospital

Discussion

Member takes

Implication

Requires prompt high-dose corticosteroids with early ICI-myocarditis recognition; reinforces rapid immunosuppression as standard in cardio-oncology.

Key Points

This research aims to detail the clinical presentation and management strategies for immune checkpoint inhibitor-associated myocarditis.
Review of clinical presentation of myocarditis following immune checkpoint inhibitor therapy.
Analysis of pathogenesis involving T-cell activation and tumor–cardiac antigens.
Evaluation of diagnostic challenges and multimodal diagnostic approaches including cardiac biomarkers and imaging techniques.
Discussion on management protocols including corticosteroids and immunomodulatory therapies.
ICI-associated myocarditis is a rare but severe cardiac adverse event leading to high mortality.
Early initiation of high-dose corticosteroids improves patient outcomes.
Challenges in diagnosis persist due to nonspecific symptoms and preservation of left ventricular function.
Complex decision-making is required for ICI rechallenge, balancing benefits and risks.

Cite This Study

Thukral et al. (2026) studied this question. Early recognition and prompt initiation of high-dose corticosteroids improve outcomes in patients with rare but life-threatening immune checkpoint inhibitor-associated myocarditis.

synapsesocial.com/papers/69cd7b475652765b073a932d https://doi.org/10.1097/crd.0000000000001257

Topics

Myocarditis

View Full Paper

Ask AI

Bookmark

Implication

Requires prompt high-dose corticosteroids with early ICI-myocarditis recognition; reinforces rapid immunosuppression as standard in cardio-oncology.

Immune Checkpoint Inhibitor–Associated Myocarditis: Current Understanding of Clinical Presentation and Management

Discussion

Member takes

Implication

Key Points

Cite This Study

Topics

Immune Checkpoint Inhibitor–Associated Myocarditis: Current Understanding of Clinical Presentation and Management

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Topics

Also Consider